How Medpace's Q3 2025 Surge and Buybacks Strategy Could Impact Medpace Holdings (MEDP) Investors [Yahoo! Finance]
Medpace Holdings, Inc. (MEDP)
Last medpace holdings, inc. earnings: 4/28 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.medpace.com
Company Research
Source: Yahoo! Finance
The company's strong organic growth, accelerating demand outlook, and history of share buybacks have drawn attention to how its business model converts clinical trial momentum into earnings power. Next, we'll explore how Medpace's strong organic revenue growth and improving demand outlook may reshape its existing investment narrative. Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave To own Medpace, you need to believe that biopharma companies will keep outsourcing complex clinical trials and that Medpace can translate that flow of work into durable earnings growth. The latest 23.7% year over year Q3 2025 revenue increase supports that thesis and aligns with the key short term catalyst of sustained organic demand, while the current weaker near and mid term sentiment does not appear to materially change the primary risk around potential slowdowns in trial funding and bookings. Among recent announcements, Medpace's aggressive s
Show less
Read more
Impact Snapshot
Event Time:
MEDP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MEDP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MEDP alerts
High impacting Medpace Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
MEDP
News
- Medpace (NASDAQ:MEDP) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- 2 Profitable Stocks to Keep an Eye On and 1 We Find Risky [Yahoo! Finance]Yahoo! Finance
- Medpace (MEDP): Assessing Valuation After Revenue Growth, Buybacks and AI-Driven Clinical Trial Expansion [Yahoo! Finance]Yahoo! Finance
- Medpace Holdings, Inc. (MEDP): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Medpace (MEDP) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
MEDP
Earnings
- 10/22/25 - Beat
MEDP
Sec Filings
- 12/9/25 - Form 4
- 12/4/25 - Form 4
- 12/4/25 - Form 4
- MEDP's page on the SEC website